MAPT and Alzheimer disease: In other clinical populations, such as AD patients, exercise interventions have reduced plasma levels of p-tau and t-tau, but not NfL [23, 24], whereas in patients with multiple sclerosis, exercise interventions have reduced plasma levels of NfL and GFAP [32].